1059 related articles for article (PubMed ID: 8795690)
21. Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
Duell T; Poleck-Dehlin B; Schmid C; Wunderlich B; Ledderose G; Mittermuller J; Kolb HJ; Schmetzer H
Acta Haematol; 2006; 116(2):131-6. PubMed ID: 16914909
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
23. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
Hirst WJ; Mufti GJ
Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.
Bae E; Park CJ; Cho YU; Seo EJ; Chi HS; Jang S; Lee KH; Lee JH; Lee JH; Suh JJ; Im HJ
Int J Lab Hematol; 2013 Dec; 35(6):629-36. PubMed ID: 23693053
[TBL] [Abstract][Full Text] [Related]
25. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
27. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
[TBL] [Abstract][Full Text] [Related]
28. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.
Tamaki H; Ogawa H; Ohyashiki K; Ohyashiki JH; Iwama H; Inoue K; Soma T; Oka Y; Tatekawa T; Oji Y; Tsuboi A; Kim EH; Kawakami M; Fuchigami K; Tomonaga M; Toyama K; Aozasa K; Kishimoto T; Sugiyama H
Leukemia; 1999 Mar; 13(3):393-9. PubMed ID: 10086730
[TBL] [Abstract][Full Text] [Related]
29. Clinical and morphological features of paediatric myelodysplastic syndromes: a review of 34 cases.
Polychronopoulou S; Panagiotou JP; Kossiva L; Mavrou A; Anagnostou D; Haidas S
Acta Paediatr; 2004 Aug; 93(8):1015-23. PubMed ID: 15456186
[TBL] [Abstract][Full Text] [Related]
30. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity.
Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A
Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832
[TBL] [Abstract][Full Text] [Related]
31. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: a report from the Childrens Cancer Group.
Barnard DR; Kalousek DK; Wiersma SR; Lange BJ; Benjamin DR; Arthur DC; Buckley JD; Kobrinsky N; Neudorf S; Sanders J; Miller LP; Shina DC; Hammond GD; Woods WG
Leukemia; 1996 Jan; 10(1):5-12. PubMed ID: 8558938
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Oliveira AF; Tansini A; Vidal DO; Lopes LF; Metze K; Lorand-Metze I
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27748021
[TBL] [Abstract][Full Text] [Related]
33. Clinical and biological characteristics of acute myeloid leukemia with 20-29% blasts: a retrospective single-center study.
Mei C; Ren Y; Zhou X; Ye L; Ma L; Luo Y; Lin P; Xu W; Lu C; Yang H; Yu W; Mao L; Wei J; Jin J; Tong H
Leuk Lymphoma; 2019 May; 60(5):1136-1145. PubMed ID: 30301399
[TBL] [Abstract][Full Text] [Related]
34. Acute lymphoblastic leukemia following preleukemic syndromes in adults.
Escudier SM; Albitar M; Robertson LE; Andreeff M; Pierce S; Kantarjian HM
Leukemia; 1996 Mar; 10(3):473-7. PubMed ID: 8642864
[TBL] [Abstract][Full Text] [Related]
35. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
36. [Pattern analytic investigations of blast cells in myelodysplastic syndrome and secondary acute myeloid leukemia].
Baumann I; Harms H; Kuse R; Feller AC; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():135-8. PubMed ID: 1708571
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.
Blau O; Baldus CD; Hofmann WK; Thiel G; Nolte F; Burmeister T; Türkmen S; Benlasfer O; Schümann E; Sindram A; Molkentin M; Mundlos S; Keilholz U; Thiel E; Blau IW
Blood; 2011 Nov; 118(20):5583-92. PubMed ID: 21948175
[TBL] [Abstract][Full Text] [Related]
38. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.
Ogata K; Nakamura K; Yokose N; Tamura H; Tachibana M; Taniguchi O; Iwakiri R; Hayashi T; Sakamaki H; Murai Y; Tohyama K; Tomoyasu S; Nonaka Y; Mori M; Dan K; Yoshida Y
Blood; 2002 Dec; 100(12):3887-96. PubMed ID: 12393641
[TBL] [Abstract][Full Text] [Related]
40. Acute leukemia after a primary myelodysplastic syndrome: immunophenotypic, genotypic, and clinical characteristics.
San Miguel JF; Hernández JM; González-Sarmiento R; González M; Sánchez I; Orfao A; Cañizo MC; López Borrasca A
Blood; 1991 Aug; 78(3):768-74. PubMed ID: 1859889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
